Ropes & Gray Represents GHO Capital in the Sale of its Stake in BioAgilytix

In The News
November 17, 2021

Ropes & Gray represented GHO Capital in the sale of its stake in BioAgilytix, a leading global contract research organization (CRO), to Cinven. Cinven will acquire a majority stake in BioAgilytix while current majority investor Cobepa, S.A. will remain a minority investor in the company. Terms of the transaction were not disclosed. The transaction was announced on Nov. 17 in a press release. 

BioAgilytix is a global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. 

The Ropes & Gray team that advised GHO Capital Partners LLP included private equity partners Neill Jakobe and Tim Castelli (both of Chicago), private equity associate Andrew Pomranke (Chicago) and tax partner Elaine B. Murphy (Boston).